Profile
Edward Samuel is currently working as the SVP-Technical Operations at Achilles Therapeutics Plc since 2022.
Previously, he worked as the Director-Manufacturing at Cognate BioServices, Inc. from 2015 to 2017 and as the Manager-Cell Therapy Operations at Orchard Therapeutics Plc in 2017.
Dr. Samuel holds a doctorate degree from University College London and a graduate degree from King's College London.
Edward Samuel active positions
| Companies | Position | Start |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/02/2022 |
Former positions of Edward Samuel
| Companies | Position | End |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01/12/2017 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Corporate Officer/Principal | 01/05/2017 |
Training of Edward Samuel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Edward Samuel
















